Cognitive Function Analysis and qEEG Study in Long COVID-19 Syndrome Patients

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

Over than 30% individuals with COVID-19, including the asymptomatic ones, and around 80% of patients hospitalized with COVID-19 may experience post-COVID sequelae, which is commonly referred to as Long COVID Syndrome. This condition has ties to decreased cognitive function and may lead to neuropsychiatric disorders but still need to be studied further. Using a cross-sectional design, this study will analyze the relationship between cognitive function and neuropsychiatric disorders with brain wave activity in Long COVID patients. The investigators conducted assessments utilizing the quantitative electroencephalogram (qEEG) measurement method and interviews using instruments such as the MOCA questionnaire and Self Rating Questionnaire (SRQ). With this qEEG examination, the investigators hoped that there will be an imbalance/abnormality of brain wave activity that arises related to impaired cognitive function.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Post-COVID-19 patients with Long COVID-19 Syndrome

• Over 18 years old

• Willing to participate in the research

• Completed the Montreal Cognitive Assessment (MoCA) and Self Rating Questionnaire (SRQ)

Locations
Other Locations
Indonesia
Rumah Sakit Cipto Manunkusumo
RECRUITING
Jakarta Pusat
Contact Information
Primary
Yetty Ramli, MD
yettyramli@gmail.com
+62811163843
Backup
Dyah Tunjungsari, MD
penelitian.neuroui@gmail.com
+628119884224
Time Frame
Start Date: 2022-10-01
Estimated Completion Date: 2023-12-30
Participants
Target number of participants: 45
Treatments
Long COVID-19
Patients post-COVID-19 with Long COVID-19 Syndrome
COVID-19
Patients post-COVID-19 without Long COVID-19 Syndrome
Related Therapeutic Areas
Sponsors
Leads: Indonesia University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials